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Abstract
Background: Lymph node involvement is one of the most important prognostic factors in colon cancer. Twelve is
considered the minimum number of lymph nodes necessary to retain reliable tumour staging, but several factors can
potentially influence the lymph node harvesting. Emergent surgery for complicated colon cancer (perforation, occlusion,
bleeding) could represent an obstacle to reach the benchmark of 12 nodes with an accurate lymphadenectomy. So, an
efficient classification system of lymphatic involvement is crucial to define the prognosis, the indication to
adjuvant therapy and the follow-up. This is the first study with the aim to evaluate the efficacy of lymph
nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in the prognostic assessment of patients
who undergo to urgent surgery for complicated colonic cancer.
Methods: This is a retrospective study carried out on patients who underwent urgent colonic resection for
complicated cancer (occlusion, perforation, bleeding, sepsis). We collected clinical, pathological and follow-
up data of 320 patients. Two hundred two patients met the inclusion criteria and were distributed into three groups
according to parameter N of TNM, LNR and LODDS. Survival analysis was performed by Kaplan-Meier curves, investigating
both overall survival (OS) and disease-free survival (DFS).
Results: The median number of harvested lymph nodes was 17. In 78.71% (n = 159) of cases, at least 12 lymph
nodes were examined. Regarding OS, significant differences from survival curves emerged for ASA score, surgical
indication, tumour grading, T parameter, tumour stage, N parameter, LNR and LODDS. In multivariate analysis,
only LODDS was found to be an independent prognostic factor.
Concerning DFS, we found significant differences between survival curves of sex, surgical indication, T parameter,
tumour stage, N parameter, LNR and LODDS, but none of these confirmed its prognostic power in multivariate
analysis.
Conclusions: We found that N, LNR and LODDS are all related to 5-year OS and DFS with statistical significance,
but only LODDS was found to be an independent prognostic factor for OS in multivariate analysis.
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Background
Adequate study of lymph nodes status is a fundament of
right evaluation of the prognostic outcome for patients
who undergo surgery for colonic neoplasm so that the
common staging system currently used, the 7th edition of
TNM by American Joint Committee on Cancer (AJCC),
proposes parameter N for nodal evaluation [1]. In particu-
lar, N considers the number of lymph nodes involved by
metastatic diffusion of tumoural cells on histological exam-
ination, without any mention about the total number of re-
trieved nodes.
Twelve is considered the minimum number of lymph
nodes necessary to retain reliable tumour staging, but
several factors can potentially influence the lymph node
harvesting, such as patient and tumour-related factors,
but also pathological analysis and surgical technique. For
example, lymph node yield is frequently reduced in male,
elderly, obese and lower socioeconomic patients, while
large and poorly differentiated tumors, longer resection
specimens and pre-operative tumour tattooing are asso-
ciated with increased lymph node yield [2].
Emergency surgery for complicated colon cancer can
represent a trouble for the surgeon, who could come
across the necessity to balance the importance of an
adequate oncologic resection with the opportunity of a
quick control of the septic source and obtaining the
hemodynamic stabilization of the patient [3, 4]. This is
why emergency surgery can be an obstacle to reach the
benchmark of 12 nodes with an accurate lymphadenec-
tomy, in addition to all other variables that can influ-
ence the nodal harvesting.
In order to improve the accuracy of the nodal study, a
new classification of lymphatic involvement has been pro-
posed, not only in colorectal cancer.
Lymph nodes ratio (LNR) is defined as the ratio
between positive lymph nodes and the total number of
retrieved lymph nodes. It has been valued for some
types of neoplasms such as the stomach, pancreas,
bladder and breast, and some studies found that it is
more precise than the parameter N in the prognostic
evaluation in colorectal cancer [5, 6]. Otherwise, some
authors sustain that LNR accuracy is not so reliable
when the number of retrieved lymph nodes is low [7].
Furthermore, LNR does not show any advantage over
N in case of no lymph node involved in metastatic dif-
fusion, since the ratio is evermore 0.
Another classification system has been recently proposed,
that is log odds of positive lymph nodes (LODDS), defined
as the logarithm of the ratio between the positive and the
negative lymph nodes (more 0.5 both to the numerator and
to the denominator, to avoid null values). It has been tested
in gastric, breast and colorectal cancer [8], and it seems to
have a stronger predictive value on survival than N and
TNM [9–11].
To our knowledge, none of the published papers
about these new classification systems of nodal in-
volvement in colorectal cancer has been so far per-
formed on a patient who underwent urgent surgery.
Our study is the first one carried out on a selected
population of patients subjected to urgent surgery for
complicated colonic cancer.
Methods
This is a retrospective study performed on patients who
underwent urgent colon resection in Arcispedale
Sant’Anna of Ferrara for complicated colonic cancer,
confirmed by histological examination, between 1
January 2003 and 31 December 2013. Complications
included bowel obstruction, perforation and massive
bleeding on any other acute condition such as sepsis due
to elapsing conditions (for example, appendicitis, diver-
ticulitis, suppuration of the neoplastic lump). In case of
bowel obstruction, we considered only patients with
evident signs of occlusion, leaving outpatients treated
with medical therapy or endoscopy “bridge to surgery”.
We collected personal data (age, sex), clinical data
(ASA score, surgical indication, time and type of surgery,
expertise of the surgeon, tumour localization, clinical
stage of neoplasm), pathological data (length of surgical
specimen, histology, level of infiltration, grading and
lymph nodal status) and data about follow-up (possible re-
lapsing, that is loco-regional recurrence or onset of distant
metastases, death, overall and disease-free survival).
Exclusion criteria were presence of metastases at diagno-
sis (stage IV), presence of neoplastic infiltration on surgical
margins or macroscopic residual tumour (not R0 surgery),
concomitance of other neoplasms, death into the first post-
operative month and insufficient data for analysis.
The patients were distributed according to the current
staging system (TNM 7th edition), and nodal status was
assessed with histological parameter pN. For each patient,
LNR and LODDS were calculated. LNR was defined as
the number of positive lymph nodes divided by the num-
ber of total examined lymph nodes. LODDS was calcu-
lated as log (number of positive nodes + 0.5)/(number of
the total examined nodes − positive nodes + 0.5). The
patients were stratified in three classes for each parameter,
according to the cutoff values reported in previously pub-
lished studies [11]: LNR0 ≤ 0.05, 0.05 < LNR1 ≤ 0.20 and
LNR2 > 0.20; − 1.36 ≤ LODDS0, − 1.36 < LODDS1 ≤ 0.53
and LODDS2 > 0.53.
Survival analysis was performed by Kaplan-Meier
curves, and the differences between the curves were
verified through log-rank test (Mantel-Cox). Cox’s
proportional hazard model was used for univariate
and multivariate analyses, considering a significant p
value < 0.5.
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Table 1 OS results
Variables n % 5-year
OS (%)
p value
(log-rank test)
Univariate analysis
(HR, 95% CI)
Multivariate analysis
(HR, 95% CI)
Sex 0.3399
M 98 48.52 46.94
F 104 51.48 50.96 0.8296 (0.5630–1.2224)
ASA < 0.0001
1 1 0.51
2 73 37.63 64.38 0.1482 (0.002899–7.5709)
3 113 58.25 43.36 0.3089 (0.006054–15.7561)
4 7 3.61 14.29 1.2455 (0.01672–92.7711)
5 0 0
Surgical indication 0.0332
Occlusion 157 77.72 50.32
Perforation 13 6.44 23.08 2.4624 (0.9303–6.5173)
Bleeding 23 11.39 56.52 0.8341 (0.4609–1.5095)
Other 9 4.45 44.44 1.2497 (0.4689–3.3308)
Type of surgery 0.0905
Right hemicolectomy 81 40.1 56.79
Left hemicolectomy 19 9.41 42.11 1.7368 (0.8361–3.6079)
Sigmoidectomy 43 21.29 51.16 1.3831 (0.8221–2.3270)
Segmental resection 33 16.34 42.42 1.4637 (0.8443–2.5375)
Hartmann 17 8.42 35.29 2.2026 (0.9800–4.9504)
Other 9 4.45 33.33 2.5408 (0.8140–7.9311)
Surgeon experience
Expert 164 81.19
Not expert 38 18.81
Istotype 0.816
Adenocarcinoma NOS 122 60.4 48.36
Carcinoma with mucinous component 39 19.31 43.59 0.9936 (0.6030–1.6373)
Mucinous carcinoma 28 13.86 53.57 0.7776 (0.4459–1.3563)
Signet ring cells carcinoma 2 0.99 50 1.011 (0.1303–7.8436)
Undifferentiated carcinoma 0 0
Mixed 4 1.98 50 1.0366 (0.2365–4.5427)
Other 7 3.46 71.43 0.4153 (0.1597–1.0801)
G 0.0274
1 8 4.06 75
2 144 73.1 50.69 2.1613 (0.8548–5.4647)
3 45 22.84 37.78 3.5917 (1.3088–9.8565)
T 0.0024
1 0 0
2 7 3.46 57.14
3 134 66.34 55.22 0.779 (0.2395–2.5339)
4a 43 21.29 27.91 1.7467 (0.4998–6.1038)
4b 18 8.91 50 0.9053 (0.2418–3.3899)
Stage 0.0143
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Results
Between 1 January 2003 and 31 December 2013, 320 pa-
tients (165 males, 155 females, median age 76 years)
underwent urgent colonic resection for complicated
colon cancer in our institute. The 70.62% (n = 226)
achieved at least 12 lymph nodes harvested, and more
than one fourth (29.38%, n = 94) did not obtain an ad-
equate study of lymph node status. One hundred eight-
een patients were excluded for stage IV (57.63%),
non-radical resection (5.08%), presence of other neo-
plasms (5.93%), death into the first postoperative month
(10.17%) and insufficient data (21.19%).
Therefore, our population was represented by 202
patients (98 males, 104 females, median age 76 years).
Most of them were classified as ASA 3 (58.25%) or ASA 2
(37.63%). These patients underwent surgery for bowel
obstruction in 77.72% of cases, bleeding in 11.39%,
perforation in 6.44% and other indications in 4.45% (seven
cases of neoplasm suppuration, one acute appendicitis, one
acute cholecystitis), and they were submitted to right hemi-
colectomy in 40.1% of case, left hemicolectomy in 9.41%,
sigmoidectomy in 21.29%, segmental colonic resection in
16.34%, Hartmann’s colostomy in 8.42% and other surgery
in 4.45% (for example, sub-total colectomy). In 26.73% of
cases, viscerolysis was associated, in 11.88% prophylactic
cholecystectomy, in 4.95% prophylactic appendicectomy, in
3.96% tenual resection and in 1.98% en bloc resection of
other abdominal organs. In 81.19% of cases, the interven-
tion was performed by an expert colorectal surgeon.
The most frequent neoplasm localization was the left
side of the colon, in particular, sigma 29.21%, sigmoid
rectal junction 10.4%, left colon 6.93% and splenic flex-
ure 5.94%, followed by the right colon with 32.18%,
transverse colon 9.41% and hepatic flexure 3.96%. 1.98%
the tumour was multifocal.
The mean length of the resected colonic tract was
30.38 cm (range 6–95 cm). The median number of har-
vested lymph nodes was 17 (range 3–79). In 78.71% (n =
159) of cases, at least 12 lymph nodes were examined.
The most frequent histologic type was adenocarcinoma
NOS (not otherwise specified, 60.4%), followed by carcin-
oma with mucinous component (19.31%), mucinous car-
cinoma (13.86%), ring cell carcinoma (0.99%), mixed
histology (1.98%) and other types (3.46%). In 4.06% of
cases, the tumour was well differentiated (G1), in 73.1%
moderately differentiated (G2) and in 22.84% poorly dif-
ferentiated (G3).
The following were the patients’ distribution for the clin-
ical stage: stage I 1.98% (n = 4), stage II 51.48% (n = 104)
and stage III 46.53% (n = 94).
Survival analysis was performed by Kaplan-Meier
curves, and differences between curves were evaluated
Table 1 OS results (Continued)
Variables n % 5-year
OS (%)
p value
(log-rank test)
Univariate analysis
(HR, 95% CI)
Multivariate analysis
(HR, 95% CI)
I 4 1.98 50
II 104 51.48 57.69 0.6444 (0.1411–2.9434)
III 94 46.53 39.36 1.1417 (0.2480–5.2562)
Number of examined lymph nodes 0,0645
≥ 12 159 78.71 39.53
< 12 43 21.29 51.57 0.6614 (0.4012–1.0903)
N 0.0053
0 108 53.46 57.41
1 61 30.2 42.62 1.5446 (0.9951–2.3975)
2 33 16.34 33.33 2.1957 (1.2084–3.9896)
LNR < 0.0001
0 120 59.41 56.67
1 49 24.26 48.98 1.1791 (0.7515–1.8499)
2 33 16.34 21.21 2.9812 (1.5726–5.6517)
LODDS < 0.0001
0 89 44.06 62.92
1 80 39.6 45 1.6684 (1.1060–2.5170) p = 0.0251
1.7593 (1.0759–2.8767)
2 33 16.34 21.21 3.6757 (1.9145–7.0570) p < 0.0001
4.2842 (2.4192–7.5869)
The entries in bold are those with statistical significance (p < 0.05)
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Table 2 DFS results
Variables n % 5-year
DFS (%)
p value
(log-rank test)
Univariate analysis
(HR, 95% CI)
Multivariate analysis
(HR, 95% CI)
Sex 0.0139
M 98 48.52 65.31
F 104 51.48 81.73 0.5038 (0.2939–0.8639)
ASA 0.4824
1 1 0.51
2 73 37.63 71.23
3 113 58.25 76.11 0.9383 (0.5326–1.6531)
4 7 3.61 71.43 2.2056 (0.2657–18.3117)
5 0 0
Surgical indication 0.0065
Occlusion 157 77.72 73.89
Perforation 13 6.44 46.15 2.9382 (0.8069–10.6997)
Bleeding 23 11.39 91.3 0.3116 (0.1368–0.7099)
Other 9 4.45 66.67 1.438 (0.3631–5.6956)
Type of surgery 0.7739
Right hemicolectomy 81 40.1 77.78
Left hemicolectomy 19 9.41 63.16 1.5884 (0.6262–4.0293)
Sigmoidectomy 43 21.29 76.74 1.2044 (0.5777–2.5113)
Segmental resection 33 16.34 69.7 1.4012 (0.6457–3.0406)
Hartmann 17 8.42 70.59 1.7488 (0.5734–5.3333)
Other 9 4.45 66.67 1.8544 (0.4404–7.8083)
Surgeon experience 0.1181
Expert 164 81.19 63.16
Not expert 38 18.81 76.22 0.6192 (0.3081–1.2443)
Istotype 0.2991
Adenocarcinoma NOS 122 60.4 74.59
Carcinoma with mucinous component 39 19.31 69.23 1.2165 (0.5973–2.4776)
Mucinous carcinoma 28 13.86 78.57 0.7532 (0.3477–1.6315)
Signet ring cells carcinoma 2 0.99 50 5.2445 (0.06004–458.1240)
Undifferentiated carcinoma 0 0
Mixed 4 1.98 50 2.0194 (0.2771–14.7187)
Other 7 3.46 85.71 0.4487 (0.1164–1.7303)
G 0.2498
1 8 4.06 87.5
2 144 73.1 75.69 2.0746 (0.5407–7.9603)
3 45 22.84 68.89 3.2203 (0.7561–13.7156)
T 0.0003
1 0 0
2 7 3.46 85.71
3 134 66.34 81.34 1.3148 (0.3095–5.5851)
4a 43 21.29 51.16 4.2641 (0.9084–20.0169)
4b 18 8.91 66.67 2.4171 (0.4551–12.8374)
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Table 2 DFS results (Continued)
Variables n % 5-year
DFS (%)
p value
(log-rank test)
Univariate analysis
(HR, 95% CI)
Multivariate analysis
(HR, 95% CI)
Stage 0.0067
I 4 1.98 75
II 104 51.48 82.69 0.7248 (0.1144–4.5923)
III 94 46.53 63.83 1.7553 (0.2743–11.2331)
Number of examined lymph nodes 0.3275
≥ 12 159 78.71 81.70
< 12 43 21.29 71.70 1.4498 (0.7441–2.8248)
N 0.0007
0 108 53.46 82.41
1 61 30.2 68.85 1.9121 (1.0413–3.5111) p = 0.0729
1.8505 (0.9478–3.6131)
2 33 16.34 54.55 3.4804 (1.5203–7.9677) p = 0.0022
3.13 (1.5150–6.4668)
LNR 0.0001
0 120 59.41 80.83
1 49 24.26 71.43 1.5172 (0.8051–2.8592)
2 33 16.34 51.52 3.7601 (1.5941–8.8694)
LODDS 0.0001
0 89 44.06 82.02
1 80 39.6 73.75 1.5093 (0.8499–2.6803)
2 33 16.34 51.52 4.0509 (1.6798–9.7690)
The entries in bold are those with statistical significance (p < 0.05)
Fig. 1 Kaplan-Meier survival curves about overall survival for N0, N1 and N2 patients
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using the log-rank test. We considered significant p
values < 0.05. We performed univariate and multivari-
ate analyses using Cox’s proportional hazard model.
Both overall survival (OS) and disease-free survival
(DFS) were considered. Results are resumed in Table 1
(OS) and Table 2 (DFS).
Mean follow-up was 64 months (range 1–154 months).
Regarding OS (Table 1), significant differences from
survival curves emerged for ASA score, surgical indi-
cation, tumour grading, T parameter, tumour stage,
N parameter, LNR and LODDS. Respectively, OS
scores were 57.41% for N0, 42.62% for N1, 33.33%
Fig. 2 Kaplan-Meier survival curves about overall survival for patients stratified by lymph nodes ratio (LNR)
Fig. 3 Kaplan-Meier survival curves about overall survival for patients stratified by log odds of positive lymph nodes (LODDS)
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Fig. 4 Kaplan-Meier survival curves about disease-free survival for N0, N1 and N2 patients
Fig. 5 Kaplan-Meier survival curves about disease-free survival for patients stratified by lymph nodes ratio (LNR)
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for N2, 56.67% for LNR0, 48.98% for LNR1, 21.21%
for LNR2, 62.92% for LODDS0, 45% for LODDS1
and 21.21% for LODDS2. In multivariate analysis, only
LODDS was found to be an independent prognostic
factor.
Concerning DFS (Table 2), we found significant
differences between survival curves of sex, surgical
indication, T parameter, tumour stage, N parameter,
LNR and LODDS, but none of these confirmed its
prognostic power in the multivariate analysis since
we found statistical significance for N2 curve only.
Discussion
Lymph node involvement is one of the most important
prognostic factors in colon cancer [1]. An adequate
lymphadenectomy is crucial for correct treatment and
staging of colonic cancer, but several factors can affect
lymph node harvesting [2]. Emergent surgery for com-
plicated colon cancer (perforation, occlusion, bleeding)
could represent a further difficulty to perform a correct
oncologic resection with an adequate lymphadenectomy.
In our experience, more than one fourth of patients
(29.38%) did not reach the benchmark of 12 examined
lymph nodes. So, an efficient classification system of
lymphatic involvement is crucial to define the prognosis,
the indication to adjuvant therapy and the follow-up.
LNR seems to be more accurate than N because it is
less influenced by a total number of harvested lymph
nodes [12], but it is useless in N0 patients.
Some studies showed the prognostic superiority of
LODDS compared with N and LNR [9, 10] and its
usefulness in node-negative patients [11].
Our study is the first one conducted on a selected
population of a patient subjected to urgent surgery for
complicated colonic cancer.
We found that N, LNR, and LODDS are all related to
5-year OS (Figs. 1, 2 and 3) and DFS (Figs. 4, 5 and 6)
with statistical significance, but only LODDS was found
to be an independent prognostic factor for OS in multi-
variate analysis.
In our experience, about one fourth of node-negative
patients (24.32%) had less than 12 retrieved lymph nodes.
Twenty-six of 111 (23.42%) of N0 and LNR0 patients
were classified LODDS1, which converged into a class
of higher prognostic risk. Five of 26 (19.23%) patient
N0 but LODDS1 experienced a disease recurrence. It
is hard to say if these patients could have benefited from
an adjuvant therapy, but it is legitimate to think that these
patients could have received a more accurate assessment
of prognostic risk if LODDS had been considered for the
cancer staging.
Our study has some limits. This is a retrospective study
carried out on a single-centre database with a limited num-
ber of patients, insufficient to draw definitive conclusions.
Conclusions
Despite the limits of our study, we can conclude that
either LNR and LODDS could be included in the prog-
nostic assessment of a patient subjected to urgent
Fig. 6 Kaplan-Meier survival curves about disease-free survival for patients stratified by log odds of positive lymph nodes (LODDS)
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surgery for complicated colonic cancer. We found that
LODDS is an independent prognostic factor for OS of
these patients.
Further studies are necessary to evaluate the efficacy
of LNR and LODDS to predict the DFS and to confirm
their usefulness in prognostic assessment in urgent co-
lonic surgery.
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